Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2.
Stefanik M, Strakova P, Haviernik J, Miller AD, Ruzek D, Eyer L.
Microorganisms · research-article; journal article · DOI 10.3390/microorganisms9030471 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för helioxanthin. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
13 träffarHelioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.
Lin YM, Kuo WW, Velmurugan BK, Hsien HH, Hsieh YL, Hsu HH, Tu CC, Bau DT, Viswanadha VP, Huang CY.
Environ Toxicol · journal article · DOI 10.1002/tox.22204The Total Synthesis of Retrojusticidin B, Justicidin E, and Helioxanthin.
Kao TT, Lin CC, Shia KS.
J Org Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.joc.5b00866Synthesis and biological evaluation of helioxanthin analogues.
Janmanchi D, Lin CH, Hsieh JY, Tseng YP, Chen TA, Jhuang HJ, Yeh SF.
Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2012.11.037LC-MS/MS determination and pharmacokinetic study of four lignan components in rat plasma after oral administration of Acanthopanax sessiliflorus extract.
Song Y, Deng Y, Huang D, Wen J, Liu Z, Li F.
J Ethnopharmacol · journal article · DOI 10.1016/j.jep.2012.03.034Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
Ying C, Tan S, Cheng YC.
Antivir Chem Chemother · journal article; research support, n.i.h., extramural · DOI 10.3851/imp1686Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
Janmanchi D, Tseng YP, Wang KC, Huang RL, Lin CH, Yeh SF.
Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2009.12.038Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
Tseng PC, Hsu HC, Janmanchi D, Lin CH, Kuo YH, Chou CK, Yeh SF.
Biochem Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2008.08.023The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
Tseng YP, Kuo YH, Hu CP, Jeng KS, Janmanchi D, Lin CH, Chou CK, Yeh SF.
Antiviral Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.antiviral.2007.12.011Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.
Ying C, Li Y, Leung CH, Robek MD, Cheng YC.
Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.0609883104Synthesis and antiviral activity of helioxanthin analogues.
Yeo H, Li Y, Fu L, Zhu JL, Gullen EA, Dutschman GE, Lee Y, Chung R, Huang ES, Austin DJ, Cheng YC.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm034265aInhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.
Li Y, Fu L, Yeo H, Zhu JL, Chou CK, Kou YH, Yeh SF, Gullen E, Austin D, Cheng YC.
Antivir Chem Chemother · research support, non-u.s. gov't; journal article · DOI 10.1177/095632020501600305Inhibition of prostaglandin E(2) production by taiwanin C isolated from the root of Acanthopanax chiisanensis and the mechanism of action.
Ban HS, Lee S, Kim YP, Yamaki K, Shin KH, Ohuchi K.
Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0006-2952(02)01348-5